Processa Pharmaceuticals, Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/698681b6-c8a8-4cf6-bf45-df05a48f3cb1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009730 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008156 |
| FY 2016 | $5.0k | 2016-01-01 – 2016-12-31 | evidence 0001393905-17-000290 |
| FY 2015 | $74.6k | 2015-01-01 – 2015-12-31 | evidence 0001393905-17-000190 |
| FY 2014 | $101.1k | 2014-01-01 – 2014-12-31 | evidence 0001393905-15-000193 |
| FY 2013 | $451.1k | 2011-03-29 – 2014-03-31 | evidence 0001393905-14-000288 |
| FY 2012 | $190.1k | 2012-01-01 – 2012-12-31 | evidence 0001393905-14-000131 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Processa Pharmaceuticals, Inc. — all facts · Net Income · Operating Income